Wael Harb
Head of R&D and Scientific Strategy, Early Phase Oncology
Syneos Health
Bio:
Dr. Wael Harb brings 23 years of medical oncology and hematology practice and 15 years of drug development experience to his role at Syneos Health. Previously, he established Horizon Oncology Center (HOC) in Lafayette, Indiana, which later became the launching pad for Verdi Oncology, a national oncology management company. He also founded Horizon Oncology Research (HOR), a premier site for early phase oncology trials in North America, where he supervised more than 100 trials with over 1,000 patients enrolled. Based in California, Dr. Harb is recognized for his leadership in advancing personalized cancer care.